Pharmaceutical composition for treating gout and application thereof

A composition and medicine technology, applied in the field of pharmaceutical compositions for treating gout, can solve problems such as single factor intervention in gout, and achieve the effects of convenient industrial production, simple and easy preparation method, and wide source of raw materials

Pending Publication Date: 2018-10-23
陶燃
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] With the in-depth research on the pathogenesis of gout and the discovery of more and more cases of liver and kidney damage caused by the first-line treatment of gout drugs, more and more scholars agree that the onset of gout is caused by multiple factors, and a single factor cannot be used to intervene in gout

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The formula of the selected pharmaceutical composition is 1000 parts of frankincense, 500 parts of curcumin, 200 parts of quercetin and 3000 parts of citronella extract. Take the medicine and decoct it with water, 3 times a day, and the course of treatment is 3 months. After several years of clinical treatment and observation of 201 patients, 156 cases were cured, with a cure rate of 77.6%; 21 cases were markedly effective, with a markedly effective rate of 10.4%; the total effective rate was 88%.

Embodiment 2

[0036] The formula of the selected pharmaceutical composition is 5000 parts of frankincense, 3000 parts of curcumin, 3000 parts of quercetin and 3000 parts of citronella extract. Take the medicine and decoct it with water, 3 times a day, and the course of treatment is 3 months. After several years of clinical treatment and observation of 201 patients, 164 cases were cured, with a cure rate of 81.5%; 25 cases were markedly effective, with a markedly effective rate of 12.4%; the total effective rate was 93.9%.

Embodiment 3

[0038] The formula of the selected pharmaceutical composition is 3000 parts of frankincense, 1500 parts of curcumin, 1500 parts of quercetin and 1500 parts of citronella extract. Take the medicine and decoct it with water, 3 times a day, and the course of treatment is 3 months. After several years of clinical treatment and observation of 201 patients, 173 cases were cured, with a cure rate of 86.0%; 27 cases were markedly effective, with a markedly effective rate of 13.4%; the total effective rate was 98%.

[0039] According to clinical observation, the formula of Example 3: 3000 parts of frankincense, 1500 parts of curcumin, 1500 parts of quercetin, and 1500 parts of citronella extract has the best effect, and the recovery rate reaches 86.0%.

[0040] The raw materials of this example, frankincense, curcumin, quercetin and citronella extract were all purchased from Shaanxi Senfu Group Company.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating gout and application thereof. The pharmaceutical composition is prepared from the following medicines in parts by weight: 500 to 3000parts of curcumin, 200 to 3000 parts of quercetin, 500 to 3000 parts of lemon-grass extract, and 1000 to 5000 parts of frankincense. The pharmaceutical composition has the advantages that the excellent anti-gout effect is realized; the pharmaceutical composition is used for preparing medicines, health-care products or foods for treating or preventing gout arthritis and / or hyperuricemia; the side effect is small, the cost is low, the preparation method is simple, and the industrialized production is easy.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to a pharmaceutical composition for treating gout and its application Background technique [0002] The number of patients with hyperuricemia in my country has reached 170 million, of which more than 80 million patients with gout, and is increasing rapidly at an annual growth rate of 9.7%. It is estimated that by 2020, the number of people with gout will reach 100 million. Nowadays, gout has become the second largest metabolic disease in my country after diabetes, and it is a health warning that cannot be ignored. The harm of gout is not only joint damage, but related complications (cardiovascular and cerebrovascular diseases, liver and kidney dysfunction) are the main causes of death in gout patients. [0003] Gout is a disorder of uric acid metabolism in the body, resulting in the deposition of uric acid crystals in the joints. It has the characteristics of multiple complications, long cou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/899A61P19/06A61P19/02A23L33/10A23L33/105A61K31/12A61K31/352
CPCA23L33/10A23L33/105A23V2002/00A61K31/12A61K31/352A61K36/324A61K36/899A61P19/02A61P19/06A61K2300/00A23V2250/21A23V2200/30
Inventor 陶燃周美群
Owner 陶燃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products